Results 11 to 20 of about 6,046 (238)

Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis [PDF]

Scientific Reports
Contrast-induced acute kidney injury (CIAKI) is an important clinical complication that occurs after the application of contrast agent in percutaneous coronary intervention. The pathogenesis of CIAKI is complex.
Xuan Wang, Shan Han, Lili Zhao, Hongliang Cong   +3 more
doaj   +2 more sources

Effect of some prostanoid receptor modulators on cholinergic and purinergic pathways in rat model of hemorrhagic cystitis: potential beneficial action of selexipag and alprostadil. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Gerges EM, Helmy MM, Daabees TT, Senbel AM.   +3 more
europepmc   +3 more sources

Alprostadil

Reactions Weekly
Leslie SW, Jain A, Iqbal OA.
europepmc   +8 more sources

Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction [PDF]

New England Journal of Medicine, 1996
Otto I. Linet, Francis G. Ogrinc
exaly   +2 more sources

How effective are alprostadil and hydrocortisone on reperfusion injury in kidney after distant organ ischemia?

Journal of Research in Medical Sciences, 2013
Background: After reestablishment of blood flow to ischemic limb recirculation of free radicals may cause ischemia-reperfusion injury in many organs. This study designed to investigate effects of hydrocortisone and alprostadil distant injury to kidneys ...
Ali Ebrahimi, Fereshteh Salimi, Mansour Safaei, Hamid Melali, Amir Hosein Davarpanah Jazi, Mehdi Nematbakhsh, Nematbakhsh Mokhtari, Hamidreza Rasooli   +7 more
doaj   +2 more sources

Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil [PDF]

New England Journal of Medicine, 1997
Wayne J G Hellstrom
exaly   +2 more sources

Risk of priapism after dynamic penile Doppler ultrasound: Single-centre experience on a large cohort of patients. [PDF]

Andrology
Abstract Objectives To evaluate the risk of priapism in patients undergoing Dynamic—Penile duplex ultrasound (D‐PDU) who were referred to our Unit between January 2022 and December 2023. Patients and methods We enrolled 292 patients, of whom 268 underwent Dynamic—Penile duplex ultrasound for erectile dysfunction and 24 for Peyronie's disease.
Grande G, Graziani A, Scafa R, Delbarba A, Caretta N, Palego P, Ferlin A.   +6 more
europepmc   +2 more sources

The effect of topical and intraurethral alprostadil on erectile function: A systematic review and meta-analysis. [PDF]

Andrology
Abstract Background Erectile dysfunction (ED) affects up to 50% of men over 40. While phosphodiesterase‐5 inhibitors (PDE5i) are the first line of medical treatment, they are not always effective. Alprostadil, available in injectable, topical, and intraurethral forms, offers an alternative treatment modality.
Papadopoulos I, Tishukov M, Sokolakis I, Katafigiotis I, Leotsakos I, Karavitakis M, Marcon J, Stief CG, Pyrgidis N.   +8 more
europepmc   +2 more sources

Efficacy and Mechanism of Alprostadil in Diabetes Mellitus Combined with Peripheral Atherosclerosis. [PDF]

Anatol J Cardiol
Yin H, Wan Q.
europepmc   +3 more sources

Comparison of protective effects of alprostadil with Salvia miltiorrhiza against myocardial ischemia-reperfusion injury in rats

Revista Portuguesa de Cardiologia, 2022
Objectives: Our study aimed to investigate the effects of alprostadil and Salvia miltiorrhiza extract on myocardial ischemia-reperfusion injury (IRI) and related underlying molecular mechanisms.
Jing Liu, Hui-Bo Chen, Wei-Zhi Sun, Xiao-Xia Jin, Wei Zhang, Yan-Bo Yang, Ya-Ru Li, Xiu-Li Chen, Jing-Bo Hou   +8 more
doaj   +1 more source